Nebenwirkungen · Selincro
Selincro 18 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 6
HOS-127557 · Präparat HOS-096425
Confusional state and, rarely, hallucinations and dissociation were reported in the clinical studies. The majority of these reactions were mild or moderate, associated with treatment initiation, and of short duration (a few hours to a few days). Most of these adverse reactions resolved during continued treatment and did not recur upon repeated administration. While these events were generally short- lasting, they could represent alcoholic psychosis, alcohol withdrawal syndrome, or comorbid psychiatric disease.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-10-07T14:41:00Z · SHA-256 33e306a05073974202b9dcd16eeb2a7e14ad94d43e4edbbf04adc0b88df7e8a1 · Passage 385d2a4c71997cbc28915a39cd0d42135cc0d284e065739defef8e323f8299a1 · Zeichen 404–919 im Abschnitt